Octagon Capital Advisors »

Ventyx Biosciences shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Ventyx Biosciences (VTYX) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Ventyx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ventyx Biosciences held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ventyx Biosciences by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.5M 2.4M 2.31
2024-03-31 $8.3M 1.5M 5.50

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Structure Therapeutics Sponsored Ads (GPCR)
Dyne Therapeutics (DYN)
Arrivent Biopharma (AVBP)
Verona Pharma Sponsored Ads (VRNA)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)
Ocular Therapeutix (OCUL)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)

View all positions for Octagon Capital Advisors

Top funds holding Ventyx Biosciences

Citadel Advisors
Deerfield Management Company
BlackRock
Farallon Capital Management
Tang Capital Management
Vanguard Group
Octagon Capital Advisors
Redmile Group
Goldman Sachs Group
Vestal Point Capital
Geode Capital Management
Opaleye Management
State Street Corporation
Parkman Healthcare Partners
Schonfeld Strategic Advisors

View all funds holding Ventyx Biosciences